Innovation and Research

Labs, patents and what's next.

  • 9 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Innovation and Research


medicaldaily.com > tecentriq-fda-approval-stage-3-dmmr-colon-cancer-479802

Tecentriq Plus Chemotherapy Wins Approval for Stage III dMMR Colon Cancer After Halving Recurrence or Death Risk

51+ min ago   (1065+ words) People with stage III colon cancer whose tumors lack a working DNA repair system now have an approved immunotherapy option after surgery. The U.S. Food and Drug Administration approved atezolizumab, sold as Tecentriq, on Oct. 8 for use with chemotherapy containing a…...


oncodaily.com > voices > joshua-zeidner-605385

Joshua Zeidner Celebrates Promotion to Full Professor of Medicine at UNC Department of Medicine

7+ hour, 48+ min ago   (57+ words) Joshua Zeidner, Professor of Medicine at the University of North Carolina at Chapel Hill, shared on X: “Celebrating promotion to full Professor of Medicine UNC Lineberger, UNC Department of Medicine. Lucky and privileged to have the best and most supportive colleagues....


medium.com > @savantframeworkadmin > antibiotics-anaphylaxis-and-the-architecture-of-refusal-31ea7f979d4b

Antibiotics, Anaphylaxis, and the Architecture of Refusal

3+ hour, 50+ min ago   (203+ words) CLAI-OS treats both as engineering problems. Two Tier II modules encode the remedy as executable governance. Global guidance is unambiguous — intramuscular epinephrine into the anterolateral thigh, immediately, repeated every five to fifteen minutes, no absolute contraindications. Yet antihistamine-first practice persists…...


medium.com > @peshwarnag > how-lime-is-using-ai-to-turn-scooters-and-e-bikes-into-an-intelligent-transportation-network-79a1e369c427

How Lime is using AI to turn scooters and e-bikes into an intelligent transportation network

3+ hour, 38+ min ago   (569+ words) That is why AI is not a side feature at Lime. It is becoming the decision layer connecting riders, vehicles, operations teams, and cities. This is the invisible side of the product. A rider sees a nearby bike on a…...


bioengineer.org > tiny-radioactive-seeds-offer-new-hope-for-thyroid-cancer-that-resists-iodine-therapy

Tiny Radioactive Seeds Offer New Hope for Thyroid Cancer That Resists Iodine Therapy

44+ min ago   (55+ words) A new review highlights how iodine-125 seed brachytherapy, delivering continuous low-dose radiation directly into tumors, is emerging as an effective and minimally invasive option for thyroid cancers that no longer respond to radioactive iodine. News Source: Nathaniel Bowman. (October 10, 2026). Tiny…...


pulse2.com > university-of-houston-receives-2-5-million-cullen-foundation-gift-for-centennial-transformation

University Of Houston Receives $2.5 Million Cullen Foundation Gift For Centennial Transformation

7+ hour, 9+ min ago   (305+ words) The University of Houston received a $2.5 million gift from The Cullen Foundation to support its Centennial grounds transformation as the university approaches its 100th anniversary. The contribution will help fund redevelopment of central campus spaces and will name Cullen Lawn within…...


paktribune.com > global-immune-cell-map-links-ageing-patterns-to-later-disease-risk

Global immune-cell map links ageing patterns to later disease risk

9+ hour, 2+ min ago   (285+ words) Researchers have developed a detailed map of how the human immune system changes with age, identifying cellular patterns associated with later chronic illness and mortality. The findings, published in Immunity on October 9, may help explain why people of the same…...


ua.news > en > health > u-britaniyi-32-patsiienti-ne-mali-retsidivu-raku-kishkivnika-33-misiatsi-sciencedaily

In Britain, 32 patients had no bowel cancer recurrence for 33 months — ScienceDaily

29+ min ago   (174+ words) In the United Kingdom, no recurrences were recorded among 32 patients with stage II or III bowel cancer during 33 months of follow-up in the NEOPRISM-CRC clinical trial. Before surgery, participants received up to nine weeks of immunotherapy with pembrolizumab, ScienceDaily reports....


eilla.ai > selling-under-5m

The AI-Native M&A Advisory for SMBs

17+ hour, 2+ min ago   (154+ words) We combine top-tier M&A advisors with AI to deliver faster, higher-value outcomes for small and medium businesses. Your deal is run by top-tier M&A advisors, ensuring a professional process. Our AI does a lot of the manual tasks…...